ihme client services

What ihme client services does

IHME Client Services is a Seattle-based social enterprise housed within UW Medicine that commercializes the Institute for Health Metrics and Evaluation's (IHME) Global Burden of Disease (GBD) study for for-profit and nonprofit buyers. Founded in 2018 as a commercial arm of IHME (which itself was established in 2007 at the University of Washington), the unit sells licensed access to the GBD — a peer-reviewed epidemiological database comprising 39+ billion rows covering 365+ diseases, 2,500+ subtypes, and 97+ risk factors across 204 countries and 900+ subnational units — via a dedicated client portal that bundles data download, visualization tools, online training, and consultation time.

The product portfolio spans raw data licensing and four bespoke analytics modules: Intervention Impact Analytics (a simulation platform modeling synthetic populations, disease states, and economic costs), Custom Future Health Scenarios (medium- to long-range forecasting including climate change pathways), Cost of Illness Analysis (payer-level spending, productivity, and caregiver-cost modeling), and Rare Disease / Disease Subtype Analysis. A portfolio of standalone visualization tools — Brain Health Atlas, Maternal Health Atlas, HIV Atlas, MICROBE, and the COVID-19 Project — extends public-facing reach and supports partnership-driven advocacy use cases.

Commercial operations follow an enterprise sales motion targeting Fortune 500 pharmaceutical companies (Gilead, GSK, Merck, Novartis, Sanofi), insurance and reinsurance carriers (Prudential, Swiss Re, Underwriters Laboratories), medical technology firms (Johnson & Johnson MedTech), healthcare systems (Mount Sinai), and major nonprofits (American Heart Association, GiveWell, Make-A-Wish International). Pricing is customized to the number of locations and conditions licensed, with annual billing; no public pricing tiers exist. Distribution is entirely direct, with no intermediaries or self-serve channel, and marketing relies on case studies, peer-reviewed publications in Lancet/JAMA/NEJM, and a website contact form funnel — a textbook relationship-driven, consultancy-led go-to-market model for high-trust, high-context health data licensing.

Name

ihme client services

Legal name

IHME Client Services

Website

https://ihmeclientservices.org

Company type

Private

Founded year

2018

Operating status

Operating

Short description

IHME Client Services is a UW Medicine social enterprise that licenses IHME's Global Burden of Disease data and provides custom analytics to pharmaceutical, insurance, healthcare, government, and nonprofit organizations worldwide.

Ownership category

akta.pro rank

Product category

Health Data Analytics and Epidemiological Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industries

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), Data Linkage, Registries & Longitudinal Cohort Surveillance (HLAJANAM), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)

Keywords

• Population health data
• Epidemiological data licensing
• Global burden disease
• Health analytics services
• Custom health forecasting

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Data Licensing: Licensing agreements for commercial use of IHME's data and tools. Pricing based on the number of locations and conditions with options to access past trends and forecasts for every country in the world. Licenses include access via a dedicated client portal, data download and visualization tools, online training materials, and dedicated consultation time.
2. Custom Analytic Solutions: Customized data and analytic guidance services for organizations' data-driven decisions. Includes support for investments in health and impact measurement, clinical trial site selection, disease forecasting, and market analysis.
3. Client Portal Access: Dedicated client portal access included with licenses, providing data download and visualization tools, online training materials, and consultation time based on package selected.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

IHME Client Services licenses commercial access to the Global Burden of Disease (GBD) study—the world's most comprehensive epidemiological database covering 39+ billion rows of structured health data across 204 countries—and delivers custom analytic solutions built on that data. Through a dedicated client portal, data visualization atlases (Brain Health, Maternal Health, HIV, MICROBE, COVID-19), and bespoke services (Intervention Impact Analytics, Custom Future Health Scenarios, Cost of Illness modeling, and Rare Disease subtype analysis), it serves pharmaceutical, insurance, healthcare, governmental, and nonprofit organizations.

Product overview

IHME Client Services is a social enterprise offering a unified data and analytics platform built on the Global Burden of Disease (GBD) study—the world's most comprehensive epidemiological database with 39+ billion rows of structured data. The core offering centers on licensed access to GBD data via a dedicated client portal with data download and visualization tools. Analytics services include Intervention Impact analytics (using ML-powered simulation platforms to quantify intervention value), Custom Future Health Scenarios (medium/long-range forecasting), Cost of Illness analysis, and Rare Disease/Disease Subtype analysis. Supporting the platform are specialized data visualization tools including the Brain Health Atlas, Maternal Health Atlas, HIV Atlas, MICROBE platform, and COVID-19 Project dashboard. All offerings are licensed through customized pricing agreements based on location and condition scope.

Differentiator

Problem solved

Functional benefit

Products and services

• Global Burden of Disease (GBD) Study Data Access

Quantifiable outcome

• Saved hundreds of hours of staff time for pharmaceutical company preparing regulatory documentation
• +4 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

17 partnerships are on record, tiered core.

• American Heart AssociationcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with American Heart Association for health data collaboration.
• ChevroncoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Chevron for health data collaboration.
• Delos LivingcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Delos Living for health data collaboration.
• Gilead SciencescoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Gilead Sciences for health data collaboration.
• GSKcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with GSK for health data collaboration.
• Human LongevitycoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Human Longevity for health data collaboration.
• MerckcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Merck for health data collaboration.
• Mount Sinai Health SystemcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Mount Sinai Health System for health data collaboration.
• MSD for MotherscoreStrategic or Co-development PartnerIHME Client Services partnered with MSD for Mothers to understand and communicate maternal health outcomes worldwide, developing the Maternal Health Atlas platform.
• NovartiscoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Novartis for health data collaboration.
• Prudential FinancialcoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Prudential Financial for health data collaboration.
• SanoficoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Sanofi for health data collaboration.
• Sapiens Data SciencescoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Sapiens Data Sciences for health data collaboration.
• Swiss RecoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Swiss Re for health data collaboration.
• Underwriters LaboratoriescoreStrategic or Co-development PartnerIHME Client Services has had service agreements with Underwriters Laboratories for health data collaboration.
• GiveWellcoreStrategic or Co-development PartnerGiveWell partnered with IHME Client Services for formal relationship to access granular data and IHME researcher consultations for cost-effectiveness modeling.
• Research for ImpactcoreStrategic or Co-development PartnerResearch for Impact, a Singapore-based think-tank, is working with IHME Client Services and Make-A-Wish International to address pediatric disease burden data needs.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Premier Inc: Healthcare improvement and analytics company providing supply chain, clinical, and population health data to providers and life sciences. Overlap with IHME's provider-facing disease burden and quality analytics use cases.
• IQVIA: Global clinical research and real-world evidence services firm serving the same Fortune 500 pharma and life-sciences buyer base with RWE, HEOR, and market analytics. Broader portfolio but overlapping data licensing and pharma analytics use cases.
• Optum (UnitedHealth Group): Diversified health services and analytics arm of UnitedHealth, providing real-world data, HEOR, and population health analytics to pharma, payers, and providers. Broad incumbent that competes for similar pharma RWE and claims analytics spend.
• Veradigm (formerly Allscripts): EHR-linked real-world evidence and analytics provider serving life sciences research and provider analytics. Competes for similar pharma RWE licensing spend from EHR-derived de-identified data.

Direct peers

• Truveta: Health data platform built from linked EHR records across U.S. health systems, offering licensed RWE for pharma, health systems, and researchers. Comparable buyer base (pharma/biotech) and product model (licensed data + analytics) but EHR-derived rather than modeled-population.
• Tempus Labs: AI-driven precision medicine data platform licensing clinical and molecular RWD to pharma and biotech. Comparable in delivering disease-burden and patient-population analytics that inform clinical trial design and commercial strategy.
• Flatiron Health: Oncology-focused real-world evidence platform (Roche subsidiary) licensing EHR-derived clinical data to pharma and providers. Comparable RWE licensing model and pharma customer base, though narrower therapeutic focus.
• Health Catalyst: Healthcare data and analytics platform serving providers, payers, and life sciences with population health analytics. Comparable delivery model (data platform + analytic services) and similar mid-to-large healthcare buyer base.
• Definitive Healthcare: Healthcare commercial intelligence and analytics provider serving medical device, pharma, and healthcare provider customers. Comparable in monetizing proprietary healthcare data through licensed subscriptions to enterprise buyers.

Emerging players

• Airfinity: Disease forecasting and infectious disease analytics startup providing modeled projections to pharma, governments, and investors. Most directly comparable in offering disease-burden forecasts and modeled epidemiological data, but narrower therapeutic scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ihme client services